Biocryst Pharmaceuticals Q3 EPS $(0.34) Down From $(0.28) YoY, Sales $1.775M Up From $1.454M YoY

Biocryst Pharmaceuticals (NASDAQ:BCRX) reported quarterly losses of $(0.34) per share. This is a 21.43 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $1.775

Benzinga · 11/06/2019 13:19

Biocryst Pharmaceuticals (NASDAQ:BCRX) reported quarterly losses of $(0.34) per share. This is a 21.43 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $1.775 million in sales this quarter. This is a 22.08 percent increase over sales of $1.454 million the same period last year.